PATENT CLAIM ANALYSIS

Application Number: 15891785
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
Methods of treating a seizure disorder with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid (KT-II-115), or a pharmaceutically acceptable salt of any of the preceding, are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of a seizure disorder. Methods of treating Prader-Willi syndrome with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid (KT-II-115), or a pharmaceutically acceptable salt of any of the preceding, are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of Prader-Willi syndrome.

Claim (Index 25):
A method of treating an abnormal EEG signature comprising administering (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid or a pharmaceutically acceptable salt thereof to a subject having the abnormal EEG signature, wherein the abnormal EEG signature is indicative of early stage of epileptogenesis.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 88.0
- Lexical Diversity: 2.84444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15680417', '15586730', '13581187', '15289480', '12666703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683391623476742
- 35 USC 102 Novelty (BERT): 0.5374034350846338
- Combined Prediction Score: 0.7452455896213701
- Mean Citation Score: 290.8644500000001
- Max Citation Score: 381.6023
- Similarity Product: 277.8430204073191

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test